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Constrictive Pericarditis (CP) is an uncommon condition which is a known treatable cause of heart 
failure. It is a condition that affects people from both developed and developing countries. In 
developed countries the aetiology of CP has undergone a paradigm shift away from infectious causes 
such as tuberculosis to acquired causes such as previous cardiac surgery and mediastinal 
radiotherapy for cancer. In the developing world by far the commonest cause remains tuberculosis. 
All aspects of CP have been widely studies in developed countries however there is limited data and 
studies on the condition from developing countries and more specifically African countries where 
tuberculosis is endemic. 
In South Africa the HIV/AIDS pandemic in association with persistent widespread poverty and poor 
socio-economic conditions has ensured that the incidence of tuberculosis infection remains 
exceedingly high. There have been numerous studies done evaluating the incidence, 
pathophysiology and treatment of tuberculous pericarditis in the HIV era. There however very 
limited data available describing CP in a South African setting. 
  The objectives of this single centre study are to contrast the clinical profiles; surgical outcomes and 
short term follow up of patients diagnosed with CP at Inkosi Albert Luthuli Hospital.  Through this 
study we hope to gain insight into the effects of HIV on patients with CP and determine whether it 
has any influence on the natural history and outcomes when compared to HIV uninfected 
individuals. 
It is hoped that information gained from this study will serve to further assist medical professionals 
in their understanding  of CP and aim to improve both our management of patients with this 
debilitating condition and ultimately there life expectancy. In addition it is hoped that that study 
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Part 1: The Review of Literature 
 
1. INTRODUCTION 
Constrictive pericarditis (CP) is a chronic debilitating condition which causes restricted heart filling 
and results in heart failure causing significant morbidity and mortality(1, 2).  Importantly it remains 
one of the few treatable causes of heart failure and pericardectomy can be curative in the majority 
of patients (2, 3).  Despite a noticeable paradigm shift in aetiology in developed countries where 
previous cardiac surgery and radiation therapy have become predominant causes, in South Africa 
and many other developing countries tuberculous pericarditis remains the main cause (1, 4-6). This 
is largely due to co-existing HIV epidemic which has continues to fuel a resurgence in all forms of 
tuberculosis. The impact of HIV on the clinical profile and surgical outcomes of patients undergoing 
pericardiectomy has not been well studied. Whilst medical therapy is warranted in a selective group 
of patients with transient constrictive pericarditis, the definitive treatment for CP is surgical 
pericardiectomy for which the mortality rates remain high between 5- 15% (4, 5, 7-10). 
 
2. PERICARDIAL ANATOMY AND PATHOPHYSIOLOGY OF CONSTRICTION 
The pericardium is a fibrous, fluid-filled sac that surrounds the heart and the origin of the great 
vessels.  It consists of two layers, the visceral pericardium which is adherent to the epicardial surface 
of the heart, and the parietal pericardium which is a 2mm thick fibrous layer surrounding the heart.  
Pericardial fluid is secreted into the pericardial cavity providing lubrication between the two layers 
of pericardium. The pericardium can exert a found profound hemodynamic effect on the heart 
especially in situations where it becomes diseased (1,2). There are a variety of diseases that can 









including: acute pericarditis, chronic pericarditis, pericardial effusion with or without tamponade 
and constrictive pericarditis (2). 
In CP the thickened, fibrotic and at times calcified pericardium results in restricted diastolic filling of 
the heart (1). The restriction to filling results in elevation and equalization of filling pressures in all 
heart chambers including the inferior and superior vena cava and the pulmonary veins.  The 
resultant high atrial pressures result in abnormal early and rapid filling of the both ventricles. As a 
result of early ventricular filling (occurring during early to mid-diastole) as well as the limitation 
imposed on ventricular expansion by the thickened pericardium, ventricular filling ceases in early 
diastole when the ventricles reach their volume limit as determined by the thickened 
pericardium.(1,3,11,12) This means that ventricular filling is almost entirely limited to early diastole. 
The main consequences of this restricted diastolic filling are twofold: firstly impaired right heart 
filling results in systemic venous congestion producing signs of hepatomegally, ascites, peripheral 
oedema and at times anasarca and even cardiac cirrhosis. Secondly, impaired diastolic filling results 
in a reduced stroke volume and cardiac output which produce dyspnoea, muscle loss and cachexia.  
An important breakthrough in the understanding of the pathophysiological effects of CP was 
discovered in 1989 by Hatle et al who described the effects of dissociation of intrathoracic and 
intracardiac pressures as well as the influence of enhanced ventricular interaction.(1) Dissociation of 
intrathoracic and intracardiac pressure produces inspiratory variation in diastolic filling pressure 
across the mitral valve (1). On inspiration the decrease in intrathoracic pressure is not transmitted to 
the left heart chambers therefore producing a lower pulmonary venous to left atrial pressure 
gradient. This results in a decrease in the transmitral blood flow and underfilling of the left ventricle 
(1-3, 12). Enhanced ventricular interaction is also a direct result of the restriction to diastolic filling 
imposed by a thickened rigid pericardium (1-3,12). During inspiration underfilling of the left-sided 









of the interventricular septum (1). The opposite occurs during expiration with decrease in right 
ventricular filling and increased left ventricular filling resulting in rightward displacement of the 
interventricular septum.  These respiratory related changes in ventricular filling can be seen on 
echocardiography help distinguish CP from restrictive cardiomyopathy (1). 
Ventricular ejection fraction in not normally affected in  CP, however in cases where there has been 
longstanding chronic constriction, fibrosis and calcification may extend beyond the pericardium to 
the epicardial tissue(3). In these cases fibrosis and scarring of the myocardium occurs, and in 
patients with longstanding chronic pericardial constriction, it can result in myocardial atrophy which 
can have a direct effect on myocardial contraction (12). If the fibrosis and calcification is severe 
enough myocardial involvement may result in impaired myocardial contractility which can 
predispose to poorer outcomes following pericardiectomy. (12) This was highlighted by Seferovic et 
al who reported a series where pericardiectomy was withheld from patients who had documented 
myocardial fibrosis and atrophy which resulted in a decrease in mortality from 40% to 5% (12). 
 
3. EPIDEMIOLOGY 
Constrictive pericarditis  is a rare condition which is frequently misdiagnosed and in resource limited 
settings potentially not diagnosed at all (12). These observations may have a significant on the true 
epidemiology of the condition and is likely to have resulted in significant under reporting of cases 
which are frequently mistaken for other causes of heart failure. Pericardial constriction may develop 
after an initial episode of acute or subacute pericarditis of any aetiology and has been found to occur 
more commonly in males when compared to females with a ratio 2.04:1 (3). There are limited 
studies correlating the risk of progression from acute pericarditis to chronic CP. In a prospective 









the incidence of progression to developing CP. (13) They determined the following incidence rates 
for various different aetiologies of acute pericarditis (Table 1):  








            (13) 
In addition to the above findings it was noted that of the initial cohort, only 9 (1.8%) patients 
progressed on to develop chronic CP with a further  75( 15%) developing transient CP which resolved 
over three months(13). Due to the small number of patients who develop CP it was not possible to 
determine statistically significant predictors of progression but patients who developed CP were 
noted to have had: a fever >38oC, incessant course, large pericardial effusion, nonviral non/non 
idiopathic aetiology, cardiac tamponade and failure to response to non-steroidal drugs after a week 
of treatment (13). 
 
4. AETIOLOGY OF CONSTRICTIVE PERICARDITIS 
Over the last two decades there has been a significant shift in the epidemiology of CP in the 
developed world. (Table 2) There has been a documented declining incidence of infectious 
aetiologies such as tuberculous constriction, with iatrogenic causes such as previous cardiac surgery 
Aetiology Cases/ 1000 person-years 
Idiopathic/viral pericarditis 0.76 
Connective tissue disease/pericardial injury syndrome 4.40 
Neoplastic pericarditis 6.33 
Tuberculous pericarditis 31.65 










and mediastinal radiation becoming the commonest causes of constriction. (4, 5, 8). In South Africa 
however; along with other developing countries in Sub-Saharan Africa, India and Asia; tuberculous 
pericarditis remains the leading cause of CP (6).  It has been estimated that between 17%-60% of 
patients diagnosed with tuberculous pericarditis progress to develop chronic constriction (14-16). 
Over recent years there has been a significant focus of attention on tuberculous pericarditis with 
numerous studies undertaken profiling the disease and attempting to explain and understand the 
pathogenesis of the development of constriction from acute tuberculous pericarditis (16, 19, 22-24).  
Table 2: Aetiology of constrictive pericarditis in major series 
Investigator Country Study period n Causes 
Bertog et al(5) USA 1977- 2000 163 Idiopathic/Viral 46%, Post surgery 37%, 
mediastinal irradiation 9%, tuberculosis 3.6% 
Ling et al(4) USA 1985-1995 135 Cardiac surgery 18%, Pericarditis 16%, 
Mediastinal irradiation 13%, Infectious 2.9% 
Szabo et al(10) Germany 1985-2012 89 Idiopathic 55%, Cardiac Surgery 23.6%, 
Tuberculosis 5.6%, medistinal radiation 5.6% 
George et al(17) USA 1995-2000 98 Idiopathic 44%, Post cardiac surgery 30%, Post 
radiation 17%, Infectious 1%, Tumour 3% 
Chowdry et al(7) India 1985-2004 395 Tuberculosis 88.9%, Previous cardiac surgery 
2.36%, Malignancy 1.05% 
Mutayaba et al(6) RSA 1990-2012 121 Tuberculosis 90%, Idiopathic 5%, Miscellaneous 
4% 
Zhu et al(9) China 1990-2012 165 Idiopathic 64%, Tuberculosis 23%, Previous 
cardiac surgery 11%, Infection 1% 










4.1 Tuberculous Pericarditis  
In Sub-Saharan Africa the ongoing HIV/AIDS epidemic has resulted in a resurgence in pulmonary 
tuberculosis and its extra- pulmonary manifestations including tuberculous pericarditis (3). The 
incidence of TB pericarditis has been reported to be between 80,000 – 160,000 cases per year (18). 
In 2011 the WHO declared half a million active TB cases in South Africa. Amongst these individuals, 
60% (300,000) had co-infection with HIV.  In 2012, HSRC reported that 6.4 million South Africans 
were living with HIV (12.2%).  These figures highlight the large burden that these conditions are 
placing on the health system in South Africa. It is therefore not surprising that tuberculous 
pericarditis is the commonest cause of pericarditis in Sub-Saharan Africa (14). Reuter et al identified 
tuberculous pericarditis as the aetiology of 69.5% of patients diagnosed with a pericardial effusion in 
a single series cohort between 1995 and 2001 (19). Of the patients with a confirmed tuberculous 
aetiology, only 2 out of 162 patients (1.23%) progressed to develop CP. (19) 
The pathogenesis of tuberculous pericarditis has been well described (14, 20, 21). TB bacilli typically 
infiltrate the pericardium via one of three routes: inoculate of the lungs with retrograde lymphatic 
spread, contiguous local spread from a lung focus or haematogenous dissemination from a distant 
infectious site (20, 21). Tuberculous pericarditis has been shown to progress through four different 
pathological stages: a dry stage with predominate fibrinous exudates; an effusive stage with 
predominate lymphocytic exudates; resorptive stage with organisation, thickening and fibrosis and 
finally a constrictive phase (20).   
Once the bacteria have infiltrated the pericardium, it is the intensity of the host’s immune response 
that defines the accompanying clinical progression and the severity of the disease process (20). 
In South Africa TB pericarditis has to be considered as the most likely cause in any patient diagnosed 









majority of patients with pericardial effusion present, the diagnosis can be challenging to prove. The 
gold standard remains direct identification of acid fast bacilli (AFB) in either pericardial tissue or fluid 
culture or from adjacent alternate sites via sputum or lymph node examination (20). The sensitivities 
and specificities of AFB culture from pericardial fluid have been reported to be between 0-75% 
depending on the culture medium used (20). Sputum positive cultures have been documented to be 
between 10 & 55% (16, 20). Recently, rapid mycobacterium tuberculosis PCR tests have become 
available with reported sensitivities being 80% and 15% for tissue specimens and fluid specimens 
respectively (21). 
The introduction of antituberculous chemotherapy resulted in a dramatic improvement in the 
treatment of tuberculous pericarditis with a marked improvement in survival (14, 20). Prior to the 
introduction of antituberculous chemotherapy mortality of tuberculous pericarditis was in the region 
of 80-85% (19). Since the introduction of standard short course therapy mortality from tuberculous 
pericarditis has dropped to 17%-40%, and failure to treat patients with effusive CP results in 
approximately 90% of cases that survive progressing to develop CP (21).   
The use of adjunctive corticosteroid therapy to treat tuberculous pericarditis has been controversial 
(21). In 2014 Mayosi et al published the first large prospective cohort of 1400 patients diagnosed 
with tuberculous pericarditis in which he showed that adjunctive therapy with prednisolone reduced 
the incidence of constrictive pericarditis and hospitalization (22). Despite the standardization of 
treatment regimens for tuberculosis across the world, in Sub Saharan Africa and especially in South 
Africa we are still faced with large numbers of patients diagnosed with tuberculous pericarditis 
progression to develop constriction. The precise characteristics of what causes patients with 
tuberculous pericarditis to progress and develop constriction remains poorly understood. Clearly 









aggressive inflammation with large effusions have been reported to have an increased likelihood of 
progressing to develop chronic constrictive pericarditis (13). 
 
5. IMPACT OF HIV ON TUBERCULOUS PERICARDITIS & PROGRESSION TO CONSTRICTION 
Ntsekhe et al have reported on the profound effect that HIV infection has had on the natural history 
of tuberculous pericarditis (14). Tuberculous pericarditis has been shown in previous studies to 
account for more than 85% of pericardial effusions in HIV positive individuals (19).  In the setting of 
co-infection with HIV, tuberculosis produces a more disseminated infection with multiorgan 
involvement resulting in higher morbidity and mortality (14). Additionally, it has been reported to be 
associated with a higher incidence of myocardial involvement leading directly to impaired 
myocardial contractility (25). The actual effect of HIV on the incidence of constrictive pericarditis, 
however, still remains undetermined (3, 6). Ntsekhe et al conducted a prospective observational 
study in 2008 which proposed that HIV infection is associated with a reduced incidence of the 
development of constrictive pericarditis (26) In this study a total of 185 patients with suspected 
tuberculous pericarditis were enrolled and commenced on anti-tuberculous therapy. Of the 185 
patients none of the 33 HIV seropositive patients developed constrictive pericarditis whereas 8 
(24%) of the seronegative patients did (26).  The reason for the observed protective effect of HIV 
infection on developing constriction has been attributed to CD4 helper cell depletion which are 
known mediators of fibrogenesis thereby producing less pericardial fibrosis and thickening as well as 
fewer granulomas (26). More recently Mutyaba et al analysed a series of 121 patients undergoing 
pericardiectomy for CP at Groote Schuur hospital in Cape Town and found that only 11(14%) of the 
patients were HIV positive and that HIV infected patients had no significant differences in their 










As a result of pericardial restriction the predominant symptoms in CP are related to fluid overload 
and decreased cardiac output. Typical congestive symptoms are peripheral oedema, elevated central 
venous pressure, hepatomegaly, pleural effusions and ascites. Hepatomegaly is often associated 
with venous pulsations and invariably accompanied by ascites and leg oedema. Exertional dyspnoea, 
fatigue, palpitations, weakness and exercise intolerance are a consequence of the low cardiac 
output. In the end stage cachexia, muscle wasting and anasarca are often present. Congestive signs, 
however, are not specific to constriction and constitute the heart failure syndrome for which there is 
a variety of causes. It is often difficult to differentiate CP from restrictive cardiomyopathy or other 
entities responsible for predominantly right-sided heart failure (1, 2, 27, 28). This dilemma 
necessitates the use of imaging modalities to aid in the diagnosis of CP. Despite advances in imaging 
modalities and haemodynamic monitoring, CP remains a diagnostic challenge in the modern era of 
medicine, and should be considered in any patient presenting with unexplained systemic venous 
congestion.  
With the availability of two dimensional / Doppler echocardiography, distinguishing constrictive 
pericarditis from other causes of right heart failure has become considerably easier.  Currently the 
basis of confirming or establishing a diagnosis of CP rests in carefully assessing cardiac function by 
means of two dimensional echocardiography supported with CT or MRI imaging in a patient 
presenting with clinical features typical of constrictive pericarditis. In most cases it is possible to 
make a diagnosis purely using non-invasive techniques; however in a few instances the diagnosis still 
necessitates full heart catheterization (1, 11). 
The jugular venous pressure is almost always elevated in constrictive pericarditis with a noticeable 
deep y descent (2, 11). Other important signs to elicit on cardiac clinical examination which may 









i) Kussmals sign is due to an increase systemic venous pressure on inspiration and is due to 
the loss of normal increased right sided venous return on inspiration. 
ii) Pulsus paradoxus  It occurs in approximately one third of patients and originates 
because of lack of transmission of the decreased intrathoracic pressure to the left heart 
chambers (11). 
iii) Pericardial knock, a diastolic sound ( early S3) brought about by the rapid halt to 
ventricular filling in early diastole, may also be difficult to discern from a third heart 
sound  due to other causes of heart failure (28). 
 
There are no specific diagnostic electrocardiographic (ECG) features that are considered diagnostic 
of constrictive pericarditis, although low voltages, nonspecific t wave changes, left atrial 
enlargement and atrial fibrillation have been frequently documented (2, 3, 28, 29). Typical 
radiological features in constrictive pericarditis include bilateral pleural effusions with a shaggy heart 
border and, in some instances, pericardial calcification. Calcification of the pericardium has been 
reported to be present in approximately 25% of patients with constrictive pericarditis and is 
frequently associated with atrial fibrillation (4). It is most easily seen on lateral radiograph and is 
most commonly located over the right ventricular and diaphragmatic surfaces of the heart (2). 
Although the cardiovascular examination provides a physician with many diagnostic clues to suggest 
CP, it cannot reliably exclude other conditions such as restrictive cardiomyopathy needs supportive 
investigation such as imaging with echocardiography, computer tomography scanning, magnetic 
resonance imaging scanning or at times heart catheterization. 
 
6.1 Echocardiography 
Two dimensional Doppler echocardiography serves as the single best initial investigation of patients 









advances in echocardiographic techniques with the development of pulsed tissue Doppler, colour 
Doppler tissue imaging and speckle- tracking imaging. Echocardiographic parameters that support 
constriction Sayed et al (3) include: 
(1) increased pericardial thickness   
(2) abnormal ventricular septal motion on m mode;  
(3) dilatation and absent or diminished collapse of the IVC and hepatic veins;  
(4) restrictive mitral and tricuspid inflow velocities, typically with respiratory variation   
(5) preserved or increased medial mitral annulus early diastolic (e´) velocity M Mode  
 
 
6.2 Cardiac Computed Tomography  
Computed Tomography (CT) of the heart is a valuable imaging modality in diagnosing constrictive 
pericarditis. It can identify pericardial thickening (>4mm) and calcification (2). In addition it can show 
evidence of IVC dilation and pick up abnormal ventricular contouring as well as abnormal septal 
motion (3). It is important to note that constrictive pericarditis can still be present in the absence of 
pericardial thickening or calcification. Ling et al. documented the absence of both pericardial 
thickening as well as calcification in approximately 20% of patients with surgically proven 
constrictive pericarditis (4). 
 
6.3 Cardiac Magnetic Resonance Imaging 
Cardiac Magnetic Resonance Imaging (MRI) is of value when echocardiographic imaging is uncertain. 
It has been shown to be especially useful in identifying the following: 
i) Ongoing pericardial inflammation 
ii) Enhanced ventricular interdependence with respiratory variation in ventricular 









iii) Blood flow velocities from atrioventricular valves 
iv) Alterations in ventricular filling with respiration    (3) 
 
 
6.4 Cardiac catheterization 
Despite advances in imaging techniques the distinction between CP and restrictive cardiomyopathy 
frequently presents a diagnostic dilemma to the clinician (2, 3). Both can have very similar clinical 
presentations and clinical findings and invariably requires the use of a combination of Doppler 
echocardiography, Cardiac CT or Cardiac MRI and on occasion cardiac catheterization to distinguish 
the two conditions and make the correct diagnosis. Clinically both conditions can present with 
systemic venous congestion and elevated jugular venous pressures.  Typically a pericardial knock 
occurs in constrictive pericarditis and an S3 in restrictive cardiomyopathy but often they can be 
confused for one another. ECG and CXR are often non-specific and unhelpful and it is mainly on 
echocardiography where one can identify several distinguishing features which can make the correct 
diagnosis. The typical cardiac catheterization findings in patients with constrictive pericarditis 
include 
i) Increased intra-atrial pressure 
ii) Prominent x and y descents 
iii) Equalization of end diastolic filling pressures in heart chambers 
iv) Dip and plateau / Square root sign of ventricular pressure 
v) Opposing changes in left and right ventricular filling and systolic pressure with 











7. MANAGEMENT OF CONSTRICTIVE PERICARDITIS 
7.1 Medical Therapy 
A small percentage of patients have been documented to develop transient constrictive pericarditis 
(21).  Strang et al, in a case series from South Africa, described that approximately 15-20 % of 
patients diagnosed with tuberculous CP who were commenced on antituberculous therapy showed 
evidence of resolution of constriction and improvement of symptoms (15). In the overwhelming 
majority cases constrictive pericarditis is a chronic progressive condition that does not respond to 
medical therapy and requires surgical management in the form of a pericardiectomy to definitively 
treat the condition (5, 10, 24, 31). Medical management of symptoms fluid overload and oedema 
with salt restriction and diuretics but pericardiectomy is ultimately required.  
7.2 Surgical Therapy 
Pericardiectomy involves radical excision of as much parietal pericardium as possible to allow for 
unrestricted atrial and ventricular contraction. The extent to which the pericardium can be excused 
is dependent on the amount of thickening, fibrosis and often calcification present and at times the 
fibrosis and calcification can extend and invade the myocardium as well (13). Total pericardectomy is 
defined as wide excision of the pericardium extending from anterior surface to the phrenic nerves 
posteriorly, superiorly to include the great vessels and the intracardiac portion of the superior vena 
cava and right atrial junction and inferiorly to the diaphragmatic surface to include the right atria – 












8.  OUTCOMES 
8.1 Immediate Outcome 
Pericardiectomy for constrictive pericarditis has a high perioperative mortality of between 5- 15% (4-
6, 8, 9, 27, 29).  There have been many studies over the years contrasting the clinical profiles and 
outcomes of patients undergoing pericardectomy for constrictive pericarditis. In reality despite 
advances in surgical technique and perioperative care the morbidity and mortality of patients 
undergoing pericardectomy remains high (Table 3). 
 
Table 3: Perioperative mortality and determinants of mortality after pericardiectomy for constrictive 
pericarditis in a selection of large studies 
 
Investigator Country Study Period n Perioperative 
Mortality 
Predictors of mortality 
Bertog et al USA 1977- 2000 163 6.1 %                       _ 
Ling et al USA 1985-1995 135 6%                       _ 
Szabo et al Germany 1985-2012 89 7%                       _ 
George et al USA 1995-2000 98 7.1% Cardiopulmonary bypass 
Chowdry et al India 1985-2004 395 7.6%                       _ 
Mutayab et al RSA 1990-2012 121 14% Serum sodium, NHYA class IV 
Zhu et al China 1990-2012 165 5.4%              NYHA class 
 
The profile of patients in South Africa with tuberculous pericarditis on the background of HIV 
infection makes our patient profile very different to those of developed countries where most of the 
outcome studies have been conducted. In South Africa there have been limited studies done on 









perioperative mortality in 109 patients who underwent pericardiectomy; 97% of patients made a 
good post operative recovery with resolution of physical signs of constriction(33). HIV infection was 
not reported in this series. 
More recently Mutuyaba et al reported a series of 121 patients in the Western Cape undergoing 
pericardiectomy for constrictive pericarditis where 91% of patients had probable or proven 
tuberculous pericarditis and 11.6% were HIV positive (16). Perioperative mortality rate was 14% ;  
preoperative serum sodium levels and NYHA class IV dyspnoea were identified as independent risk 
factors of early mortality (6). With specific reference to HIV infected patients in the cohort no 
significant difference was found both in clinical profile and outcomes compared to HIV negative  
patients (6). 
8.1.2 Long Term Outcome 
In South Africa to date there have been no studies done documenting the long term follow up of 
patients with constrictive pericarditis. Good long term outcomes have been confirmed in other 
studies done primarily in developed countries.  Bertsog et al reported five year death rates for 
patients post pericardiectomy for CP of 19% before 1990 and 21% thereafter (5).  In India Chowdry 
et  al documented long term survival in a cohort of 395 patients with 338(85%) undergoing total 
pericardiectomy ( Group 1) and 57( 14.4%) undergoing partial pericardectomy ( Group 2) as being 
83.8 % at 17.9 years  for group 1 and 73.9% for group 2 (7). In addition preoperative high right atrial 
pressure, hyperbilirubinemia, renal dysfunction, atrial fibrillation, pericardial calcification, 
thoracotomy approach, and partial pericardiectomy we identified as predictors of mortality (7). 
9. RATIONALE FOR THIS STUDY 
Constrictive pericarditis is one of the few treatable causes of heart failure as surgical pericardectomy 









is associated with a high degree of morbidity and mortality. Although the effect of HIV infection on 
the clinical outcomes and management of patients with tuberculous pericarditis has been well 
studied there is little data on the profile of constrictive pericarditis in HIV infected subjects. Recent 
studies have suggested that HIV alters the natural history of tuberculous pericarditis with fewer 
patients progressing to develop constriction. Our study aims to compare the clinical profile and 
surgical outcomes of patient with confirmed constrictive pericarditis in HIV infected and non-
infected individuals. We hope to assess whether HIV infection, in an era where patients have had 
access to antiretroviral therapy, has had any significant impact of the clinical course of patients with 
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Title of Study: 
 The effects of HIV/AIDS on the clinical profile and outcomes post pericardectomy of patients with 
constrictive pericarditis. A retrospective review. 
Aim of Study: 
1. To evaluate the effect that HIV/AIDS has on the clinical profile of patients with constrictive 
pericarditis and  
2. To evaluate outcomes in those patients undergoing pericardiectomy. 
Specific Objectives (SO): 
1. Assessment of clinical profile including:  
 Demographic data (age, gender, ethnicity, residential address) 
 Co morbid conditions ( Diabetes Mellitus, Hypertension, Hypothyroidism 
 HIV status 










 Clinical Presentation ( New York heart association class of dyspnoea ) 
 Physical examination ( Peripheral oedema ,ascites ,pleural effusion, elevated jugular 
venous pressure, pericardial knock, pulsus paradoxus  
 Biochemistry ( Haemoglobin, potassium, sodium, urea, creatinine, liver function 
tests, CRP, ESR, BNP, CD4 count, HIV viral load, Hepatitis B surface antigen) 
 Results of imaging ( Chest X ray, Chest computerized tomography ) 
2. Echocardiographic findings: 
 Features of constriction (pericardial thickness, abnormal ventricular septal wall 
motion, evidence of IVC collapse, mitral valve inflow velocity evidence) 
 Assessment of left ventricular and right ventricular function). 
3. Description of clinical outcomes: 
 medical management (diuretic usage) 
  surgical pericardectomy,  
 short term follow up post-surgery ( symptoms, Doppler echocardiogram results)  
Introduction: 
Constrictive Pericarditis (CP) is a debilitating condition arising from chronic inflammation of the 
pericardium causing thickening and fibrosis resulting in impaired diastolic filling of the heart with 
reduced ventricular function. [1, 2] Importantly it remains one of the few treatable causes of heart 
failure. [4, 5] 
CP can develop following any pericardial disease process. [5] In developed countries the commonest 
aetiologies in the modern era of medicine are idiopathic causes, cardiac surgery and mediastinal 
radiation therapy.  In developing and underdeveloped nations, where the human immunodeficiency 
virus (HIV)/ acquired immunodeficiency syndrome (AIDS) pandemic is highly prevalent, tuberculosis 










In most cases of CP, diagnosis is established with non-invasive testing. Computerised tomography 
(CT) scanning and echocardiography provide imaging modalities that confirm constriction in most 
cases. However, in spite of these advancements of the modern era of medicine, CP still poses a 
diagnostic challenge to the clinician. It remains largely undiagnosed due to difficulty in 
differentiating it other causes of right heart failure and from restrictive cardiomyopathy (RCMO). 
In those patients in whom a diagnosis is confidently established, options for management are 
restricted to a few. Medical therapy to treat the right heart failure may be offered, but the definitive 
management is surgery with pericardiectomy. [1-5, 14-17] The challenge faced here by the attending 
physician lies in the selection of patients for surgery with regard to the risk – benefits ratios to the 
patient. Pericardiectomy carries a high mortality rate of 5 - 12% but unfortunately is also currently 
the only curative treatment in the majority of cases. [1, 3, 5, 14 -16] 
 
 Anatomy and Pathophysiology: 
The pericardium is a fibrous, fluid filled sac surrounding the heart and the roots of the great vessels 
providing structural support, protection from infection and lubrication for heart movement. These 
functions allow it to have a significant haemodynamic impact on the heart. [5] The pericardium is 
not an essential structure and the heart can function normally in its absence either congenitally or 
from surgical resection. However, in clinical settings when the pericardium becomes diseased, 
cardiac function is disrupted. This may present clinically as acute or chronic recurrent pericarditis, 
pericardial effusion, and in severe cases, cardiac tamponade, and pericardial constriction. All of 
these manifestations of pericarditis can be challenging to manage and possibly life-threatening in 









 The pathophysiological hallmark of CP is restriction to diastolic filling of the heart secondary to a 
thickened, fibrotic pericardium. This results in elevation and equilibration of filling pressures in all 
chambers of the heart and the systemic and pulmonary veins. As a result of the equalisation, almost 
all ventricular filling occurs in early diastole, limiting end diastolic volumes, and producing decreased 
left and right ventricular stroke volumes. This decrease in stroke volume causes decreased cardiac 
output and increased pre-load. The consequence of this can be appreciated as systemic venous 
congestion. This reflects clinically with signs of hepatic congestion, peripheral oedema, ascites and 
sometimes anasarca, and cardiac cirrhosis [10] 
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Impairment of ventricular filling causes a decrease in cardiac output, leading to fatigue, muscle 
wasting, and weight loss. In “pure” constriction, contractile function is preserved, until the very late 
stages when the constriction extends beyond the pericardium to the epicardial tissue. The 
myocardium is occasionally involved in the chronic inflammatory process and may become fibrosed. 
This leads to true contractile dysfunction which, at times, can be quite severe and is a prediction of a 
poor response to pericardiectomy. 
 
Epidemiology:  
Until the advent of HIV infection and its predisposition to tuberculosis CP was an uncommon 
condition. Approximately 9% of patients with acute pericarditis from any cause progress to develop 
constrictive physiology. The true frequency is dependent on the incidence of the specific causes of 
pericarditis. The risk of constrictive pericarditis following a first episode of acute pericarditis has been 
estimated in a previous study to be in the region of 1.8% [18] 
 
In developed countries, viral causes, surgery and radiation remain the main causes of pericarditis, 
leading to CP. In developing countries that are plagued with a high prevalence of HIV and poor socio-
economic situations, the commonest cause of pericarditis is tuberculosis (TB). The HIV statistics 
released by the WHO in 2011 declare half a million active TB cases in South Africa. Amongst these 
individuals, 60% (300,000) had co-infection with HIV. [9] In 2012, HSRC reported that 6.4 million 
South Africans were living with HIV (12.2%). [8] These statistics are clear indications the impact of 
the HIV pandemic on modern third world medicine. Its impact on the number of individuals infected 
with TB, and more particularly, TB pericarditis, is enormous. It is therefore not surprising that TB 









complication on TB pericarditis, documented to be present in between 30-60% of cases despite 
appropriate treatment with antituberculous chemotherapy. [6] 
 
Furthermore, there is little data on the effect that HIV/ AIDS has on the clinical characteristics of CP, 
the progression of acute effusive tuberculous pericarditis to CP and the outcomes after 
pericardiectomy.[4]  Studies done on tuberculous pericarditis have suggested that early initiation of 
anti- tuberculous chemotherapy combined with pericardiocentesis have had a significant impact in 
limiting the progression to developing CP. [11] To this effect, results from the ‘The Investigation of 
the Management of Pericarditis in Africa (IMPI Africa) Registry’ showed that HIV associated TB 
pericarditis is a more aggressive disease with a greater degree of myocardial involvement and high 
mortality rate of approximately 40%. [7, 8] In addition it has been shown that HIV has a significant 
effect on the natural history of tuberculous pericarditis with fewer HIV co-infected patients 
progressing to develop CP but having significantly higher mortality when compared to non HIV 
infected counterparts. [8, 12]  
Causes of Constrictive Pericarditis: 
Infectious Tuberculous, Bacterial, Viral (commonly coxsackie and echo viruses), Fungal 
Trauma  
Inflammatory Rheumatoid Arthritis, Systemic Lupus Erythematosus, Scleroderma, Sarcoidosis 
Neoplastic Breast and lung cancer, mesothelioma, melanoma 
Radiation Post mediastinal radiation therapy 















CP still presents a diagnostic challenge in the 21st Century. In South Africa it usually requires a 
combination of suggestive clinical signs and symptoms in patients who may or may not have been 
treated for pulmonary or extra-pulmonary TB. It presents as the heart failure syndrome but 
diagnosis of constriction requires clinical skill in searching for the signs of constriction.   
 
I. Symptoms and signs suggestive of CP: 
 
Fluid Overload Peripheral oedema, elevated central venous pressure, hepatomegally, 
pleural effusions, ascites and anasarca 
Decreased Cardiac Output Exertional dyspnoea, fatigue, palpitations, weakness and exercise 
intolerance 
 
Congestive signs are unfortunately not specific to constriction and constitute the heart failure 
syndrome for which there is a variety of causes. This dilemma necessitates the use of imaging 
modalities to aid in the diagnosis of CP. Despite advances in imaging modalities and haemodyamic 
monitoring, CP remains a diagnostic challenge in the modern era of medicine, and should be 
considered in any patient presenting with unexplained systemic venous congestion [17].  A 
comprehensive set of differential diagnoses must also be considered. The differential diagnoses 
must include: 
(1) acute dilatation of the heart 
(2) pulmonary embolism 









(4) pleural effusion 
(5) chronic obstructive lung diseases and;  
(6) restrictive cardiomyopathy 
 
The definitive diagnosis of CP is made incorporating a combination of clinical, radiological, 
echocardiographic, and haemodyamic parameters. 
 
Pericardial calcification is a highly useful suggestive marker for CP and can be seen on chest 
radiograph, being best appreciated on lateral view. It is, however, only seen in approximately 25% of 
cases but, when present, it strongly suggests constriction. [5] 
 
Echocardiography is the first choice of initial imaging and haemodyamic assessment tool available 
for use in both developed and developing countries: two-dimensional transthoracic 
echocardiographic findings include: 
(1) increased pericardial thickness   
(2) abnormal ventricular septal motion;  
(3) dilatation and absent or diminished collapse of the IVC and hepatic veins;  
(4) restrictive mitral and tricuspid inflow velocities, typically (but not always) with respiratory 
variation   
(5) preserved or increased medial mitral annulus early diastolic (e´) velocity 
 












Flow Diagram 1: Summary of diagnostic approach for constrictive Pericarditis  [5] 
Treatment: 
Constrictive pericarditis is a progressive disease but has a variable course. There have been no large 
randomized control trials profiling the natural history of this condition. Treatment options are 
generally limited. With the exception of patients with transient constriction following acute 
pericarditis, surgical pericardiectomy is the only definitive treatment for chronic constriction.[1-5] 
Patients with major comorbidities or severe debilitation are often at too high risk to undergo 
pericardiectomy and in this subgroup of patients mortality remains high. However, if not contra-
indicated, surgery should not be delayed once the diagnosis is made. Medical management with 









require surgical pericardiectomy. Results from large variety of international studies have consistently 
reported perioperative mortality rates of 5% to 15%. [2, 4, 5] Early mortality results primarily from 
low cardiac output, often in debilitated patients with prolonged cardiopulmonary bypass and 
difficult dissections.  
The highest mortality occurs in patients with Class III or IV symptoms, supporting the 
recommendation of early pericardiectomy. 
Study Design  
    ICD 10 Code confirming CP 
      YES 
    Admitted to IALCH Cardiology Ward 
    AND 
    Underwent full diagnostic work up 
    
YES     
   Diagnostic work up confirmed CP  
AND 
Patient was referred to the cardiothoracic  
surgeons for evaluation of pericardiectomy 
 
      YES 









Patients who had a complete work up done at Grey’s hospital in Pietermaritzburg with CP confirmed 
on echocardiography and CT chest, and who had been referred to the Cardiothoracic surgeons at 
IALCH for pericardiectomy were also considered eligible for the study. 
 
Patients will be selected for this study by using ICD 10 codes to identify patients who diagnosed with 
constrictive pericarditis during their visits to Inkosi Albert Luthuli Hospital (IALCH). The sample group 
will be further screened to assess which patients had both been admitted to the Cardiology Ward at 
IALCH and undergone a full diagnostic work up including: clinical assessment, blood testing 
echocardiography and chest computerized tomography. Those patients who had a full in-patient 
diagnostic work up confirming the diagnosis of constrictive pericarditis and who were referred to the 
cardiothoracic surgeons for evaluation of pericardiectomy will be considered eligible for the study. 
Patients who have had a complete work up done at Grey’s hospital in Pietermaritzburg, with CP 
confirmed on echocardiography and CT chest, and who had been referred to the cardiothoracic 
surgeons at IALCH for pericardiectomy, will also be eligible for inclusion in the study. 
.  
Study Population  
 All patients referred to IALCH for evaluation of constrictive pericarditis will been screened 
for selection into the study. The sample population of patients with confirmed CP will be 
extracted. IALCH Department of Cardiology’s capture area is Kwazulu natal (KZN) and part of 
the Eastern Cape. This will be the target population from which the sample population will 
be collected. In addition, those patients falling under the Grey’s Hospital drainage area will 












 All patients with confirmed CP based on clinical echocardiographic and radiological 
investigations during in-patient work up done at IALCH Cardiology unit or Greys Hospital will 
be included. 
 Only patients who had consented and undergone HIV testing or whose HIV status is known 
prior to admissions will be included. 
 
Exclusion Criteria 
 Patients who did not undergo in-patient evaluation for CP using diagnostic modalities of 
echocardiography, CT imaging will be excluded. 
 Patients whose HIV status is unknown will be excluded. 
 Patients who were admitted for inpatient evaluation of CP in the Department of Cardiology 




 The population sample will include all patients who meet the criteria for inclusion during 












Data Collection Methods and Tools 
Data collection will be done using Speedminer Database which is a record collection of medical data 
captured including every entry (in-patient and out-patient, investigations, doctors’ notes, 
paramedical notes and referrals) for every patient that has been to IALCH. All patients are given a 
‘Kwa-Zulu (KZ) number’. Using Speedminer Database, all patients that were seen from 2003 to 2013 
as in-patients and out-patients at Cardiology are isolated by their KZ numbers. The patients are then 
sorted manually by KZ number on the Medicom Clinician Access (CA) Live System and each file read 
and reviewed for constrictive pericarditis with exclusion and inclusion criteria followed.  
 
Data Analysis Technique  
This is a retrospective analysis of patients admitted to the Cardiology unit at IALCH who have been 
diagnosed with constrictive pericarditis. Patients will be stratified into two groups: those with HIV 
and those without HIV, based on HIV Elisa testing. Categorical variables will be analysed by chi 
squared test. Continuous variables will be assessed by rank sum test. Multivariate analysis will be 
performed to determine the factors contributing to the development of constriction and the severity 
of clinical features in both groups. 
Statistical Analysis 
Group sample sizes of 37 in group one and 37 in group two achieve 80% power to detect a minimum 
absolute difference between the group proportions of 0.27 or 27%. The proportion in group one (the 
treatment group) is assumed to be 0.11 under the null hypothesis and 0.38 under the alternative 
hypothesis. The test statistic used is the two-sided Z test with pooled variance. The significance level 










The study location is IALCH which is where the investigations take place echocardiography and CT 
scanning. The study source is the entire area that is referred to IALCH Cardiology for investigation 
further management, i.e. KwaZulu-Natal and part of the Eastern Cape.   
 
Study Period 
This is a retrospective study over 10 years, from July 2003 to December 2013. All patients that have 
been referred for investigated for constrictive pericarditis 2003 to 2013 at IALCH will be selected for. 
To ensure reliability of data, only patients who were admitted to the Cardiology Unit at IACLH or 
referred from Grey’s Hospital with a proven diagnosis of CP will be considered eligible. 
 
Limitations to the Study  
1. The study is limited to the patients referred to IALCH hospital.  
2. The study sample will be skewed towards African subjects because these are the majority of 
patients with constrictive pericarditis. The result, therefore, may not be applicable to non- 
African subjects.  
3. The sample sizes are small therefore limiting the statistical significance of the results. 
4. Long term follow up of patients remains problematic as the majority of patients are from 
distant rural areas where transport and communication difficulties limit their attendance at 










Ethical Considerations  
1. Scientific Validity 
This study is valid as it will contribute to the knowledge of the influence of HIV/AIDS on the 
clinical profile of CP and surgical outcomes following pericardiectomy. Currently, there is 
limited data from African countries on this subject. 
 
2. Social Value 
The risk factors and the financial cost incurred in performing investigations: 
echocardiography and computer tomography, as well as the need for surgical treatment 
with pericardiectomy, warrant the need to identify those patients that do indeed have 
constrictive pericarditis. The social value of this would be to prevent exposing patients to 
these investigations and potential surgical procedures when they may likely be unnecessary 
and to offer it to them when there is a likely need.   
 
3. Risk Benefit Ratio 
 
The benefits of the study are that: 
 The influence of HIV/AIDS on the clinical profile of CP and surgical outcomes following 
pericardiectomy will be better understood 
 Patients who need the investigations more may receive it  
 Patients who do not need the investigations may not be exposed to them  
 









 The results may lead to a patient needing the investigation not being offered it  
 The results may lead to a patient not needing the investigation being offered it  
 
4. Confidentiality 
This is a retrospective chart review study in which patients selected are anonymous. They 
are identified by their KZ numbers only. 
 
5. Informed Consent 
This is a retrospective study. The investigations performed were done before the study was 
designed (2003 up until 2013). Patients were informed by their consulting doctors of the 
procedures and investigations to be performed and written informed consent obtained prior 
to the investigations being performed as part of the routine hospital protocol for 
management of patients. 
 
6. Standards of Care 
The patients that form part of the study have been offered the highest standards of care 
which is a standard offered to all patients that are attended to at IALCH Cardiology. They are 
further offered further intervention that is the most beneficial and necessary for 
improvement of their quality of life and prolongation of life, based on the outcomes of 
investigations. 
 
7. Conflict of Interest  
There is no conflict of interest. 









The patients are selected according to presentation. There are no demographic criteria or 
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Objective: The clinical profile and surgical outcomes of patients with constrictive pericarditis were 
compared in HIV positive and HIV negative individuals in Durban, KwaZulu-Natal. 
Methods: This study was a retrospective analysis of all patients diagnosed with constrictive 










Results:  Of 83 patients with constrictive pericarditis 32 (38.1%) were HIV positive with a mean CD4 
count of 294 (SD+/- 127) cells/uL. Proven tuberculosis was found in 22(26.5%) subjects and 
58(69.9%) had probable tuberculosis. Except for pericardial calcification which was more common in 
HIV negative subjects (n=15; 29.4 vs n=2; 6.3%; p=0.011), the clinical profile was otherwise similar in 
both groups. Fourteen patients died preoperatively (16.9%) and three patients perioperatively 
(5.8%). On multivariable analysis, age (OR 1.17; CI 1.03-1.34; p=0.02), serum albumin (OR 0.63; CI 
0.43-0.92; p=0.016), gamma GT (OR 0.97; CI 0.94-0.1.0; p=0.034) and PA pressure (OR 1.49; CI 1.07-
2.08; p=0.018) emerged as independent predictors of preoperative mortality. Pericardiectomy was 
performed in 52(63.8%) of whom 20(39.6%) were HIV positive. There were three early perioperative 
deaths (HIV-ve(2), HIV+ve(1)). Perioperative complications occurred more frequently in HIV positive 
patients (9 (45%) vs 6(17.6%) p=0.030). 
Conclusions: The clinical profile of constrictive pericarditis is similar in both HIV negative  and 
positive subjects. Without surgery tuberculous constrictive pericarditis was associated with a high 
preoperative mortality rate. In virally suppressed subjects pericardiectomy was not associated with 
an increased early perioperative mortality.  
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Constrictive pericarditis remains an uncommon yet treatable cause of heart failure. 1, 2 The hallmark 
of constrictive pericarditis is impaired ventricular diastolic filling caused by a thickened, fibrosed 
pericardium resulting in decreased stroke volume and varying degrees of systemic venous 
congestion. 2-5 The natural history of this disorder remains unknown. 6 Whilst medical therapy has 
been used to successfully treat patients with constriction in its early stages, surgical pericardiectomy 
remains the only treatment for chronic constrictive pericarditis. 7, 8 Surgical mortality remains high 
and has been reported to be between 5 -14% in multiple large series. 1, 2, 6, 9-15  Over the past two 
decades there has been a changing spectrum of constrictive pericarditis in the developed world with 
a declining incidence of infective aetiologies, in particular tuberculosis. 1, 3 In Sub-Saharan Africa, 
tuberculosis remains the dominant cause; about 30-60% of patients diagnosed with tuberculous 
pericarditis progress to constriction despite appropriate anti-tuberculous therapy and adjunctive 
corticosteroids. 16 The co-existing HIV/AIDS epidemic has contributed to the resurgence of 
tuberculosis, and its various manifestations, including constrictive pericarditis in Africa. 2 The effect 
of HIV on the incidence, natural history and surgical outcomes of patients with constrictive 
pericarditis has not been adequately documented. 2 Recent data suggest that coexisting HIV 
infection may modify the clinical manifestations and natural history of tuberculous pericarditis and 
resultant constriction. 17, 18 Our study was designed to evaluate the clinical profile and surgical 
outcomes of HIV positive and negative patients with constrictive pericarditis.  
 
METHODS 
This study is a retrospective chart review of all patients referred to Inkosi Albert Luthuli Central 
hospital in Durban Kwazulu-Natal for evaluation and management of suspected constrictive 
pericarditis during the period 2004-2014. Patients eligible for inclusion in the study constituted those 









symptoms and signs associated with typical echocardiographic and computer tomography (CT) scan 
findings. Clinical supporting features included peripheral oedema, ascites, pleural effusions, 
hepatomegaly, elevated jugular venous pressure and pericardial knock. Typical echocardiographic 
features of constriction were a thickened echogenic pericardium accompanied by paradoxical 
interventricular septal motion, and dilated non-compressible hepatic veins and inferior vena cava. 
Thoracic CT scans were used to confirm pericardial thickening, calcification, and demonstrate lymph 
node enlargement. Tuberculosis (TB) as the cause for constrictive pericarditis was inferred from a 
history of a previous diagnosis of tuberculosis, (pulmonary or extrapulmonary), or previous 
treatment for tuberculosis. Proven tuberculosis was defined by isolation of the organism or typical 
histological findings. Patients in whom the diagnosis of constrictive pericarditis was incorrect were 
excluded from the study population. Informed consent for HIV testing was obtained from all patients 
with suspected constriction who were referred to Inkosi Albert Luthuli hospital with a view to 
surgical pericardiectomy. Relevant data (demographics, HIV status, clinical symptoms and signs and 
symptoms, laboratory, echocardiographic, radiological, operative data and follow up findings were 
extracted.  
In the subset that underwent pericardiectomy, constrictive pericarditis was confirmed 
intraoperatively by identifying constrictive features with pericardial thickening and fibrosis. Surgery 
was performed by median sternotomy without cardiopulmonary bypass in all but one patient. At 
operation the entire ventricular epicardium, apex and diaphragmatic surface of the heart was freed. 
The pericardium was removed anteriorly extending laterally to the phrenic nerves and the posterior 
pericardium was left in situ after being freed from the epicardium. Any resection less than this was 
deemed a partial pericardiectomy. Immediate perioperative mortality was defined as any death 









The study was approved by the Biomedical Research Ethics Committee of the University of KwaZulu-
Natal (BE 324/15) 
Statistical Analysis 
Data were analysed using Stata 13.0 (StataCorp. 2013. Stata Statistical Software: Release 13. College 
Station, TX: StataCorp LP). Continuous variables were summarized using mean and standard 
deviation or median and interquartile range. Difference in means of continuous predictors by HIV 
status (i.e. two groups) were assessed using the student t-test. If the data were not normal then the 
Wilcoxon rank-sum test was used instead. If the data were not normally distributed then 
the Kruskal-Wallis equality-of-populations rank test was employed instead. Association between HIV 
status (2 and 3 group classification) and categorised explanatory variables/risk factors were assessed 
using a Pearson chi-square (χ2) test. If any cell count in the cross tabulation contained fewer than 5 
expected observations then the Fishers exact test were used. Multivariate logistic regression were 
employed to estimate the strength of association (odds ratios) between the explanatory predictors 
and HIV status. A p-value of <0.05 was considered statistically significant. 
 
RESULTS 
Preoperative clinical profile 
A total of 86 patients were eligible for inclusion during the study period (Fig 1). Three patients were 
excluded, (incorrect diagnosis n=2, HIV status unknown n=1) leaving 83 (43 male, 40 female) for 
analysis. The mean age of the total sample was 37.98 ± 12.91 yr (range 19-69). Of these patients, 32 
(38.6%) were HIV positive, of whom 21 (65.6%) were on antiretroviral therapy and nineteen (59%) 
patients were virally suppressed (viral load < 1000copies/ml). In addition, a further 3 patients who 









had a CD4 count of less than 200. The baseline characteristics stratified by HIV status are 
summarized in Table 1. 
The aetiology of constriction was tuberculosis in 80/83 (96.3%) of patients. Constriction was deemed 
to have followed viral pericarditis in two patients and the third patient developed constriction 
following repeated radioablation procedures for tachyarrhythmias. Tuberculosis was proven in 22 
(26.5%) patients and was considered the probable aetiology in a further 58 (69.5%) patients. 
Although proven tuberculosis was identified more frequently in HIV positive patients (40%) 
compared to HIV negative patients (17.6%), this finding was not statistically significant.  
 
The mean body weight of HIV positive patients was 5 kg less those who were HIV negative (62.77 ± 
12.01 vs 67.69 ± 13.05; p=0.09) but this finding was also not statistically significant. Moderate 
dyspnoea (NYHA class II) was present in almost two thirds (63.9%) of the patients and severe 
symptoms were present in 32.5% of patients. Similarly, two thirds (n= 57; 68.7%) of patients had 
ascites. There was no difference in the clinical characteristics between HIV positive and HIV negative 
patients except for peripheral oedema which was significantly more frequent in HIV negative 
patients (86.2% vs 65.6%; p=0.026). Atrial fibrillation was documented in five patients (all HIV 
negative), four of whom had extensive pericardial calcification on chest radiography. 
 
All patients (n=83) had chest radiographs (CXR) and echocardiograms and 77 patients (94%) had 
thoracic CT scans. A total of 17 patients (20.5%) had pericardial calcification on CXR and one 
additional patient had pericardial calcification identified on CT scan only. Extensive pericardial 









n=2; 6.3%; p=0.011) on the chest radiograph. Mediastinal lymphadenopathy was identified in 47 
(61%) of patients and there was no difference between HIV positive and negative patients (p=0.642) 
On echocardiography effusive constrictive pericarditis was found in seven (8.4%) patients of whom 
four were HIV negative and three HIV positive (p=ns). There was no significant difference in the 
ejection fraction (51.88% ± 7.5 vs 52.69% ± 4.96; p=0.593), and pulmonary arterial pressure 
(33.88mmHg ±8.86 vs 34.96mmHg ±7.76; p=0.571 between HIV negative and HIV positive patients 
respectively.  
 
Laboratory data showed no significant differences in haemoglobin, white cell count, urea, creatinine 
and albumin levels between HIV negative and HIV positive patients. Of note, alkaline phosphatase 
(146.0 ± 67.7 vs 201.0 ± 108.8; p = 0.005), and gamma glutamyl transferase (172.96+104.76 vs 





Of the initial study cohort of 83 patients with constrictive pericarditis, 31 (37.3%) patients did not 
undergo pericardiectomy. Of these 31 subjects, four died in hospital shortly after admission (all HIV 
negative) from low cardiac output and the remaining 27 offered surgery did not return for 
operation. Survival status of those lost to follow up was established telephonically as well as 
checking the national registry of deaths. In this way it was established that a further ten had 









(95% CI: 9.5-26.6 %). Bivariate logistic regression analysis identified seven predictors of preoperative 
mortality (Table 2). These were age (OR, 1.11; 95% CI, 1.04-1.18; p = <0.001), haemoglobin (OR, 0.67; 
CI, 0.45-0.99; p=0.031), albumin (OR, 0.90; CI, (0.82-0.99; p=0.019), aspartate aminotransferase (OR, 
0.91;CI 0.85-0.98; p=0.003)and pulmonary artery pressure (OR, 1.13; CI, 1.05-1.22; p= <0.001). HIV 
status had no influence on the preoperative mortality (p=0.693). On multivariable analysis, age (OR 
1.17; CI 1.03-1.34; p=0.02), serum albumin (OR 0.63; CI 0.43-0.92; p=0.016), gamma GT (OR 0.97; CI 
0.94-0.1.0; p=0.034) and PA pressure (OR 1.49; CI 1.07-2.08; p=0.018) emerged as independent 
predictors of preoperative mortality. 
 
 
Operative outcome of patients undergoing pericardiectomy 
 
A total of 52 patients (62.7%) underwent pericardiectomy, which included 32 HIV negative patients 
(61.54%) and 20 HIV positive patients (38.5%). Of the twenty HIV positive patients, 15 (75%) were on 
antiretroviral therapy with successful viral load suppression (<1000 copies/ml). Pericardial biopsy 
specimens taken at the time of surgery showed histological evidence of tuberculosis in the form of 
granulomas and/or acid fast bacilli in 12/49(24.5%) of patients. 
Complete pericardiectomy was achieved in 38 (73.1%) and there was no significant difference 
between HIV positive and negative patients (26; 81.3% vs 12; 60%; p= 0.093). There were three in-
hospital perioperative deaths yielding a perioperative mortality rate of 5.7% (95% CI 9.5-26.7%). One 
patient (HIV positive) died of intraoperative haemorrhage in theatre and two (HIV negative) who 
were both severely symptomatic preoperatively (NYHA IV) with impaired ejection fraction, died in 
ICU as a result of a low cardiac output state. There was no significant difference in the length of ICU 









Intraoperative complications included accidental myocardial wall or major vessel injury in ten 
(19.2%) patients, of whom one patient sustained massive haemorrhage and died intraoperatively 
and one patient developed ventricular fibrillation. There were two early perioperative deaths of 
patients while admitted to the ICU. Postoperative complications occurred in 7 patients (9.6%), 3 of 
whom had also suffered intraoperative complications. These postoperative complications were: 
sternal wound sepsis (1), re-intubation for respiratory failure and tachyarrhythmia (1), thoracotomy 
for postoperative haemorrhage(1), postoperative renal impairment(1) and low output cardiac 
failure(3). In total perioperative (intra- and post-operative) complications occurred significantly more 
frequently in HIV positive patients (HIV positive, 9; 45% vs HIV negative, 6; 17.6%; p=0.030). The 
higher complication rate in HIV positive patients could not be explained by left ventricular function 
since the left ventricular function was similarly preserved in both groups (HIV negative, 53.33% ± 6.7 
vs HIV positive, 53.93 ± 6.79; p=0.783). In total there were 3 perioperative in-hospital deaths 




Of the 49 patients who were discharged (3 died in hospital) after undergoing pericardiectomy, 41(26 
HIV positive) returned for the six week postoperative follow up at our hospital. Six patients were 
followed up at their referral hospital and 2 were lost to follow up. Most patients improved their 
NYHA class by one or two levels (p<0.001)(Fig 1). The majority of patients had improved from NYHA 
class II to class I (n = 21, 50%) and NYHA class III to class I (n = 10, 23.8%).  Eight patients showed no 
improvement in functional class. There was no significant difference in symptoms of dyspnoea 












This study shows a relatively high prevalence rate of HIV infection 32/83 (38.6%) amongst patients 
with constrictive pericarditis. HIV infection did not appear to influence early postoperative mortality. 
The HIV prevalence in our study is higher than 14/96 (14.6%) that reported by  Mutyaba et al 2 in a 
recent South African study but less than 12/19 (63%) reported by Abubaker and colleagues 17 in a  
Nigerian study. Our findings contrast with  Gopaldas et al 18 in the USA who found ten HIV positive 
patients with constrictive pericarditis out of a sample size of 3847 undergoing pericardiectomy. In 
keeping with other studies from developing countries 2, 11, 12, 19-21  tuberculosis 80 (96.4%) was 
identified as the main aetiology of constrictive pericarditis in our study and highlights the impact of 
the HIV/AIDS epidemic in refuelling a resurgence of tuberculosis infections. (24, 25) Similar to other 
series, (2, 15)  proven tuberculosis (pericardial histology, culture of AFB from sputum, lymph nodes) 
was documented in 22(26.5%) of patients.  
The natural history of tuberculous pericarditis has been previously described, including treatment 
options to prevent progression to constriction 16, 28, 30-32.  In contrast to Reuter’s findings in TB 
pericarditis 26 we found histological evidence of definite tuberculosis in only nine operative 
pericardial biopsy specimens and could not determine from these small numbers whether 
histological evidence of tuberculosis is more common in HIV positive subjects.  
Similar to Mutyaba et al (2), we have shown few differences in the clinical profile between HIV 
positive and HIV negative patients. Higher levels of alkaline phosphatase and gamma glutamyl 
transferase among HIV positive patients might have been due to hepatic tuberculosis or more likely 
to more severe hepatic congestion in these subjects. Of note there was no difference in the 
preoperative and follow up ejection fraction between HIV positive and HIV negative patients. This 









been found to have a higher prevalence of myopericarditis.27,28 Although only three patients died, 
preservation of ejection fraction might explain why we found no significant differences in 
perioperative mortality observed between HIV positive and negative patients. It is also likely that 
antiretroviral therapy in our patients may have helped to preserve left ventricular function by 
preventing the development of opportunistic infection or HIV associated myocardial dysfunction. 
Pericardial calcification was identified on chest radiography in 17(20,5%)  of our study patients, 
which is similar to that reported in a recent series by Mutyaba et al 2 but much higher than the 5% 
reported by Strang et al in the pre HIV era. 19  Equivalent rates of pericardial calcification in HIV 
positive and HIV negative patients (21.4% vs 20.7%; p = 0.953) have been described in Mutyaba et al 
study2. In contrast, we found that pericardial calcification was an uncommon finding in HIV positive 
patients compared with HIV negative patients (6.3% vs 29.4%; p=0.011). Furthermore none of the 
eight patients with CD4 counts < 200 developed pericardial calcification. We attributed the higher 
prevalence of pericardial calcification amongst HIV negative patients to longer survival in these 
patients with prolonged duration of inflammation and progression to calcification; alternatively it 
could be explained by the suppression of CD4 helper by the HIV virus leading to less fibrogenesis and 
calcification in these subjects. 26 
 
Among the 31 subjects who did not undergo surgery, 15 patients were still alive at follow-up                            
(survival status unknown in 2) and 5 reported improvement in their symptoms. Given that these 
patients had been diagnosed with tuberculous constriction and received antituberculous therapy it 
highlights what has been described previously by Strang et al 29: a significant number of patients 
diagnosed with tuberculous constrictive pericarditis may undergo resolution of their symptoms on 
anti-tuberculous therapy. The high preoperative mortality rate of 16.78% emphasizes the 









antituberculous therapy. Our analysis of the preoperative outcome showed that HIV status had no 
influence on the preoperative mortality in constrictive pericarditis. Of the 14 deaths 4 were HIV 
positive. On bivariate analysis, older age, unsuppressed viral load, lower serum haemoglobin and 
albumin levels were shown to predict preoperative mortality. On multivariate analysis age, serum 
albumin, gamma GT and pulmonary artery pressure emerged as independent predictors of 
mortality. 
 
 Operative Outcomes. On analysis of patients undergoing pericardiectomy, we found that complete 
pericardiectomy was less likely to be achieved in HIV positive (n= 9, 50%) as compared to negative 
patients (n=37, 71%). Also perioperative complications appeared to be more common in HIV positive 
patients undergoing pericardiectomy. Whether this could be due to more inflammation with 
anatomical distortion making surgery more difficult is not clear. An important finding in our study is 
that we found no difference in the short term peri-operative outcome between HIV positive and HIV 
negative patients. Our perioperative mortality rate of 5.7% is consistent with that reported in the 
majority of series worldwide.(6, 9, 11-14, 18) Of two South African based studies, our in hospital 
perioperative mortality rate of 5.7% was higher that of Fennel et al (12) (4/109; 3.7%) in the pre-HIV 
era but less that the 14% 30 day perioperative mortality found by Mutyaba et al 2 in their series.  
At the six week follow up visit, most patients in our series showed significant improvement in NYHA 
class (p = <0.001). (Table 5), with improvement in at least one functional class to NYHA I (78.6%) and 
NYHA II (21%). This finding is consistent with reported by Mutyaba et al 2 and Tetty et al. 20  












Our study has limitations related to its retrospective design, including a number of patients lost to 
follow up whilst awaiting surgical pericardiectomy.  Despite this we were able to obtain survival 
status in in most patients preoperatively and were able to show that number of subjects demised 
while awaiting surgery. Furthermore long term patient follow up was often not possible. Based on 
the available patient records we could only accurately comment on in-patient perioperative 
mortality and early six week follow up of postoperative patients.     
 
CONCLUSION  
This finding has important clinical implications: It shows that constrictive pericarditis is associated 
with a high preoperative mortality and emphasizes the benefits of surgery in patients who do not 
respond to antituberculous therapy.  It also shows that whilst HIV infection is associated with a 
higher in hospital complication rate, early peri-operative mortality is unaffected in subjects who are 
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Figure 1: Early outcome of patients with constrictive pericarditis 
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TABLE 1:  Baseline characteristics of study patients stratfied by HIV status
Characteristic All HIV negative HIV Positive P  valve
 (n = 83) (n = 51) (n =32)
Age (y) 37.98 ± 12.91 38.82 ± 14.56 36.63 ± 14.56 .454
Weight 65.75 ± 12.81 67.69 ± 13.05 62.77 ± 12.01 .091
Gender .245
   Male 43(51.8) 29(56.9) 14(43.75)
   Female 40(48.2) 22(43.1) 18(56.35)
Cause of constrictive pericarditis .140
   Probable tuberculosis 58(69.9) 39(76.5) 19(59.4)
   Proven tuberculosis 22(26.5) 9(17.6) 13(40.6)
   Other 3(3.6) 3(5.9) 0
NYHA functional class .841
    I 3(3.6) 2(3.9) 1(3.1)
    II 53(63.9) 33(64.7) 20(62.5)
    III 22(26.5) 12(23.5) 10(31.3)
    IV 5(6.0) 4(7.8) 1(3.1)
Examination
      SBP (mm HG) 110.83 ± 11.85 110.78 ± 11.67 110.91 ± 12.32 .964
      DBP (mm HG) 70.57 ± 10.63 71.43 ± 9.86 69.19 ± 11.78 .352
      Pulse rate (beats/min) 88.76 ± 14.72 86.35 ± 14.74 92.59 ± 14.05 .060
      Jugular venous pressure 77( 92.8) 48(94.1) 29(90.6) .358
      Pericardial knock 43(51.8) 24(47.1) 19(59.4) .274
      Hepatomegally 76(91.6) 46(90.2) 30(93.8) .767
      Ascites 57(68.7) 35(68.3) 22(68.8) .991
      Oedema 65(78.3) 44(86.2) 21(65.6) .026
Chest x-ray
   Pericardial calcification 17(20.5) 15(29.4) 2(6.3) .011
   Pleural effusion 67(80.7) 43(84.3) 24(75.0) .295
Echocardiography
    Ejection fraction (%) 52.19 ± 6.61 51.88 ± 7.50 52.69 ± 4.96 .593
    End diastolic dimension (mm) 47.95 ±7.93 47.4 ±7.92 48.81 ± 8.01 .435
    Left atrial size (mm) 43.85 ±8.57 44.86 ± 9.5 42.28 ± 6.70 .185
    Septal bounce 81(97.6) 49(96.1) 32(100.0) .257
    Pulmonary Artery Pressure (mmHg) 34.31 ± 8.41 33.88 ± 8.86 34.96 ± 7.76 .571
 Dilated IVC and hepatic veins 73(97.3) 45(100.0) 28(93.3) .157
CT chest and mediastinum ᵏ
    Pleural effusion 58(75.3) 37(80.4) 21(67.7) .282
    Pericardial thickening 73(94.8) 45(97.8) 28(90.3) .297
    Pericardial calcification 18(23.4) 15(32.6) 3(9.7) .032
    Lymphadenopthy 47(61.0) 27(58.7) 20(64.5) .642
Laboratory results: mean +-SD
    Haemaglobin g/dL 12.78 ± 1.75 12.91 ± 1.76 12.58 ± 1.74 .418
    White cell count  (10 ⁹/L) 5.15 ± 1.47 5.25 ± 1.48 4.99 ± 1.46 .444
    Platelets   (10 ⁹/L) 251.86 ± 84.37 244.20 ± 79.82 264.06 ±  91. 11 .299
    Sodium ( mmol/l) 136.96 ± 3.33 137.27 ± 3.50 136.47 ±  3.03 .286
    Urea (mmol/l) 6.58 ±2.57 6.40 ± 2.79 6.86 ± 2.20 .429
    Creatinine (µmol/l) 81.70 ± 20.51 81.76 ± 20.05 81.59 ± 21.55 .971
    Albumin   (g/l) 37.60 ± 6.33 38.04 ± 5.99 36.91 ± 6.89 .431
    Aspartate aminotransferase  (U/L) 39.35 ± 13.59 37.22 ± 10.51 42.28 ± 16.69 .110
    Alanine aminotransferase  (U/L) 25.21 ± 16.94 20.71 ± 10.70 32 ± 22.09 .002
    Alkaline phosphatase  (U/L) 167.40 ± 89.50 146.02 ± 67.70 201 ± 108.82 .005
    Gamma glutamyl transferase  U/L) 249.16 ± 224.09 172.96 ± 104.76 370 ± 300.59 <.001
 for dilated IVC and hepatic veins for 8 subjects (6 HIV negative and 2 HIV positive).
Data presented as mean ± standard deviation for continuous variables and n (%) for categorical variables. NYHA , New York Heart Association; IVC , 














Table 2: Bivariate logistic regression model of  factos associated with preoperative mortality
Alive Preoperative  death
Characteristics n = 69 n = 14 Odds ratio (95% CI) P value
Age: mean+-sd 35.4+-11.7 50.7+-11.0 1.11 (1.04-1.18) <0.001
Gender
   Female 33(47.8) 7(50.0) 0.92 (0.29-2.89) .882
   Male 36(52.2) 7(50.0)
HIV Positive .693
 CD4 > 200 21(30.4) 3(21.4) 0.59(0.15-2.36)
 CD4 < 200 7(10.1) 1(7.1) 0.59(0.65-5.32)
NYHA Class 69(100) 14(100) 1.50 (0.65-3.48) .351
Haemaglobin g/dL 12.96 ± 1.70 11.91 ± 1.78 0.67 (0.45-0.99) .031
White cell count  (10 ?/L) 5.17 ± 1.45 4.99 ± 1.58 0.91 (0.61-1.37) .660
Platelets   (10 ?/L) 257 ± 89.01 224.64 ± 49.96 0.99 (0.99-1.00) .160
Sodium ( mmol/l) 137 ± 3.33 136 ± 3.28 0.91 (0.77-1.07) .243
Urea (mmol/l) 6.37 ± 2.17 7.6 ± 3.96 1.17 (0.96-1.42) .131
Creatinine (µmol/l) 80.37 ± 20.87 88.21 ± 17.94 1.02 (0.99-1.04) .192
Albumin   (g/l) 38.35 ±  6.29 33. 93 ± 5.37 0.90 (0.82-0.99) .019
Aspartate aminotransferase  (U/L) 41.16 ± 13.71 31.36 ± 9.97 0.91 (0.85-0.98) .003
Alanine aminotransferase  (U/L) 25.87 ± 16.88 22 ± 17.52 0.98 (0.94- 1.03) .403
Alkaline phosphatase  (U/L) 175.94 ± 93.06 125.29 ± 54.11 0.99 (0.98-1.00) .061
Gamma glutamyl transferase  U/L) 269.39 ± 235.30 149.43 ± 119.43 1.00 (0.99-1.00) .071
Ejection fraction (%) 51.97 ± 6.75 53.29 ± 6.06 1.03 (0.94-1.13) .491
Pulmonary artery pressure (mmHg) 32.80 ± 6.88 43 ± 11.19 1.13 (1.05-1.22) <0.001
Data presented as mean ± standard deviation for continuous variables and n (%) for categorical variables. NYHA, New York Heart Association. CI,
 confidence interval.
TABLE 3:  Operative characteristics of study patients stratified by HIV status
Characteristic All  (n = 52) HIV Negative (n = 32) HIV positive (n = 20) P value
Pericardiectomy .093
Total 38(73.1) 26(81.3) 12(60.0)
Sub-total 9(17.3) 2(6.3) 7(35.0)
Not known 5(9.6) 4(12.5) 1(5.0)
Inotrope usage ᵖ 48(94.1) 31 (96.9) 17(85.0) .547
Days in ICU 4.59 ± 2.84 4.28  ± 2.74 5.11  ± 2.84 .321
Post  operative Complications 15(28.9) 6(18.8) 9(45.0) .030
Pericardial histology ᵗ
    Granulomas 9(18.4) 4(12.9) 5(27.8) .259
    Acid fast bacili 3(6.1) 1(3.2) 2(11.1) .546
    Calcification 12(24.4) 10(32.3) 2/18(11.1) .168
Post operative Ejection fraction ᵘ 53.55  ± 6.65 53.33  ± 6.70 53.93  ±  6.79 .783
Post operative six week follow upᵛ .687
NYHA I 33(80.4) 20(76.9) 13(86.7)
NYHA II 9(21.4) 6(23.1) 2(18.8)
Ejection fraction ᵞ 53 ± 9.16 52.44 ± 11.50 53.83 ± 4.67 .785
Data presented as mean ± standard deviation for continuous variables and n (%) for categorical variables. ICU , Intensive care unit.
NYHA , New York Heart Association. ᵖ Details of inotrope usage was not availabe for 1 subject. ᵗ 3 Subjects histology results were not   
found ( 1 HIV negative, 2 HIV positive).ᵘ 9 subjects did not have post operative measurement of ejection fraction ( 4 HIV negative  
subjects and 5 HIV positive subjects). ᵛ 41 patients attended six week follow up ( 26 HIV negative, 15 HIV positive). Follow up ejection




























FIGURE 1. Comparison of preoperative and six week postoperative New York Heart  
Association functional status in 41 patients (P<.0001). NYHA, New York Heart Association. 
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- Duration  
- NYHA class ( Preop)  
  
HIV status  
Co-Morbidities  
- Hypertension  
- Diabetes  
- Opportunistic infections ( Syphilis, hepatitis)  
Examination Findings  
- Blood Pressure  
- Heart rate  
- Pulsus paradoxus  
- Early S3  
- Inspiratory splitting S2  
- Kussmauls sign  
- Ascities  
- Pleural effusion  
- Hepatomegally  
- Atrial fibrillation  
-   
Imaging  
- X ray: Pericardial calcification  









- Echocardiography:  LV and RV function, 
septal wall motion abnormalities, IVC 
collapse, pericardial thickening 
 
Blood Results  
- Haemaglobin ( g/dl)  
- Sodium  
- Urea  
- Creatinine  
- Albumin  
- AST/ALT  
- GGT/ ALP  
- CD4 count/ Viral load  
- Hepatits B Surface antigen  
- RPR  
Treatment  
- Pericardiectomy  
- Diuretic usage   
- ICU stay  
Follow up  
- Post op: NYHA status/ Ejection fraction  
- Duration of follow up  
Complications  
 
